Gender differences in schizophrenia and first‐episode psychosis: A comprehensive literature review

S Ochoa, J Usall, J Cobo, X Labad… - … research and treatment, 2012 - Wiley Online Library
Recent studies have begun to look at gender differences in schizophrenia and first‐episode
psychosis in an attempt to explain the heterogeneity of the illness. However, a number of …

[HTML][HTML] Metabolic syndrome in people with schizophrenia: a review

M De Hert, V Schreurs, D Vancampfort… - World …, 2009 - ncbi.nlm.nih.gov
Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with
schizophrenia. Patients are at risk for premature mortality and overall have limited access to …

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the …

M De Hert, JM Dekker, D Wood, KG Kahl… - European …, 2009 - cambridge.org
People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder,
have worse physical health and reduced life expectancy compared to the general …

A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls

D Vancampfort, M Wampers, AJ Mitchell… - World …, 2013 - Wiley Online Library
A meta‐analysis was conducted to explore the risk for cardio‐metabolic abnormalities in
drug naïve, first‐episode and multi‐episode patients with schizophrenia and age‐and …

Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the …

J Bobes, C Arango, M Garcia-Garcia… - Journal of Clinical …, 2010 - psychiatrist.com
Objective: To analyze the prevalence of negative symptoms in antipsychotic-treated
outpatients with schizophrenia spectrum disorders. Method: A cross-sectional, retrospective …

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective …

M De Hert, V Schreurs, K Sweers, D Van Eyck… - Schizophrenia …, 2008 - Elsevier
The presence of the metabolic syndrome (MetS) is an important risk factor for cardiovascular
disease and diabetes. There are limited data on the prevalence of MetS in patients with …

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

JM Meyer, VG Davis, DC Goff, JP McEvoy… - Schizophrenia …, 2008 - Elsevier
BACKGROUND: The metabolic syndrome (MS) is associated with increased risk for
diabetes mellitus and coronary heart disease, and is highly prevalent among schizophrenia …

Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

P Gardner-Sood, J Lally, S Smith, Z Atakan… - Psychological …, 2015 - cambridge.org
BackgroundThe aims of the study were to determine the prevalence of cardiometabolic risk
factors and establish the proportion of people with psychosis meeting criteria for the …

Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis

N Garrido-Torres, I Rocha-Gonzalez… - Psychological …, 2021 - cambridge.org
BackgroundIt is unclear what the prevalence of metabolic syndrome (MetS) in drug-naïve
first-episode of psychosis (FEP) is, as previous meta-analyses were conducted in minimally …

Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS …

J Bobes, C Arango, M Garcia-Garcia, J Rejas - Schizophrenia research, 2010 - Elsevier
AIM: We analysed the impact of tobacco smoking over several healthy lifestyle habits along
with the impact on 10-years cardiovascular event (CVE) risk in the CLAMORS schizophrenia …